Previous 10 | Next 10 |
2023-10-04 02:20:41 ET Summary Poseida Therapeutics reported strong Q2 2023 revenue growth of 641.22% YoY, beating estimates by $14.93 million. Astellas Pharma's $50 million investment in Poseida's cancer cell therapy is a positive step after the termination of its collaboration w...
2023-09-27 08:59:28 ET Summary Poseida Therapeutics exhibits robust financials with Q2 2023 collaboration revenue surging to $20.01M and a recent $50M Astellas investment extending its cash runway. Despite stock underperformance, Poseida's diversified CAR-T pipeline shows momentum...
2023-08-29 17:26:54 ET Gainers: Vimeo ( NASDAQ: VMEO ) +6% . Twist Bioscience ( TWST ) +5% . Iris Energy ( IREN ) +4% . Poseida Therapeutics ( PSTX ) +4% . Conn's ( CONN ) +3% . Losers: Ambarella ( AMBA ) ...
2023-08-16 17:38:56 ET Gainers: Avnet ( AVT ) +8% . SunOpta ( STKL ) +8% . StoneCo ( STNE ) +5% . Repare Therapeutics ( RPTX ) +5% . ARS Pharmaceuticals ( SPRY ) +5% . Losers: The Lovesac ( LOVE ) -7% ...
2023-08-09 13:27:46 ET Gainers: Benitec Biopharma ( BNTC ) +81% . Tango Therapeutics ( TNGX ) +77% . Decibel Therapeutics ( DBTX ) +76% . T Stamp ( IDAI ) +50% . Millennium Group International Holdings ( MGIH ) +43% . EBET ( ...
Poseida Therapeutics Provides Financial Results for the Second Quarter of 2023 PR Newswire SAN DIEGO , Aug. 8, 2023 /PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage cell and gene therapy company advancing a new class of treatments for p...
2023-08-07 13:28:03 ET Gainers: Nektar Therapeutics ( NKTR ) +87% . Enveric Biosciences ( ENVB ) +47% . Sequans Communications S.A. ( SQNS ) +31% . Tabula Rasa HealthCare ( TRHC ) +31% . Missfresh Limited ( MF ) +29% . Sovos ...
2023-08-07 11:25:39 ET More on Poseida Poseida Therapeutics: Pioneering Cell And Gene Therapies Spark Excitement And Caution Poseida gains on FDA nod to start trials for CAR-T therapy Poseida stock falls ~8% postmarket after founder, executive chairman to step down ...
2023-08-07 10:15:28 ET Gainers: Poseida Therapeutics ( PSTX ) +33% . Tabula Rasa HealthCare ( TRHC ) +32% . Mallinckrodt plc ( MNK ) +17% . Assertio Holdings ( ASRT ) +18% . Palatin Technologies ( PTN ) +16% . Losers: Sag...
Poseida Therapeutics Announces Strategic Investment by Astellas and Provides Business Update PR Newswire $50 million strategic investment validates Poseida's proprietary technology and cell therapy approach and supports strategic and operational plans Implementing ...
News, Short Squeeze, Breakout and More Instantly...
Poseida Therapeutics Inc. Company Name:
PSTX Stock Symbol:
NASDAQ Market:
Poseida Therapeutics Inc. Website:
Poseida Therapeutics Announces Participation in Stifel's 2024 Virtual Cell Therapy Forum PR Newswire SAN DIEGO , July 1, 2024 /PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage allogeneic cell therapy and genetic medicines company advanci...
Poseida Therapeutics Announces Virtual 2024 Annual Meeting of Stockholders PR Newswire SAN DIEGO , June 3, 2024 /PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage allogeneic cell therapy and genetic medicines company advancing differ...
Poseida Therapeutics Provides Updates and Financial Results for the First Quarter of 2024 PR Newswire Expanded strategic relationship with Astellas with new research collaboration leveraging Poseida's proprietary allogeneic CAR-T platform to develop cell therapies targeti...